Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Non-Current Assets (2021 - 2025)

Rxo (RXO) has disclosed Non-Current Assets for 5 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 5.54% year-over-year to $2.0 billion, compared with a TTM value of $2.0 billion through Dec 2025, down 5.54%, and an annual FY2025 reading of $2.0 billion, down 5.54% over the prior year.
  • Non-Current Assets was $2.0 billion for Q4 2025 at Rxo, down from $2.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.1 billion in Q3 2024 and bottomed at $985.0 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $1.4 billion, with a median of $1.0 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets soared 111.58% in 2024, then fell 6.41% in 2025.
  • Year by year, Non-Current Assets stood at $985.0 million in 2021, then rose by 1.73% to $1.0 billion in 2022, then grew by 2.69% to $1.0 billion in 2023, then surged by 101.65% to $2.1 billion in 2024, then decreased by 5.54% to $2.0 billion in 2025.
  • Business Quant data shows Non-Current Assets for RXO at $2.0 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.